Aroyl semicarbazide derivatives against thromboembolic diseases

Details for Australian Patent Application No. 2004245187 (hide)

Owner Merck Patent GmbH

Inventors Cezanne, Bertram; Gleitz, Johannes; Tsaklakidis, Christos; Dorsch, Dieter; Mederski, Werner

Agent Davies Collison Cave

Pub. Number AU-B-2004245187

PCT Pub. Number WO2004/108718

Priority 103 25 962.7 07.06.03 DE

Filing date 12 May 2004

Wipo publication date 16 December 2004

Acceptance publication date 10 September 2009

International Classifications

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2004/108718 Priority application(s): WO2004/108718

10 September 2009 Application Accepted

  Published as AU-B-2004245187

14 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004245193-Modified wheat flour for paper production

2004245184-Phl p 5a derivatives with reduced allergenicity and retained T-cell reactivity